纤维化与酒精相关性肝病
本文综述酒精相关性肝病(ALD)纤维化的形态学特征,并与包括非酒精性脂肪性肝病(NAFLD)在内的其他慢性肝病进行比较。ALD纤维化呈小叶中央型损伤模式,进展为汇管区周围纤维化和/或细胞周围纤维化,最终导致肝硬化。目前缺乏ALD特异性纤维化分期系统,现有NAFLD分期系统用于ALD预后评估的效用可能受限。
要点
- 组织学纤维化分期是代偿期和失代偿期ALD最重要的预后因素之一。
- ALD与NAFLD纤维化呈小叶中央型模式,不同于多数慢性肝病的汇管区为基础模式。
- 目前缺乏ALD特异性分期系统,现有NAFLD分期系统用于ALD预后评估的效用可能受限。
核心结论
- ALD相关纤维化呈小叶中央型损伤模式,进展为细胞周围纤维化并最终导致肝硬化。
- 与NAFLD不同,目前缺乏能够满足临床管理和试验所需标准化预后评估的ALD特异性分期系统。
- 尽管NAFLD与ALD存在形态学相似性,但临床和组织学特征差异可能大幅限制现有NAFLD特异性分期系统在ALD预后评估中的效用。
研究设计与样本
- 综述,总结ALD纤维化形态学特征并与包括NAFLD在内的其他慢性肝病进行比较。
主要发现
- ALD和NAFLD相关脂肪性肝病呈小叶中央型损伤模式,导致汇管区周围纤维化和/或细胞周围纤维化。
- 脂肪性肝病进展驱动广泛的细胞周围纤维化,连接血管结构并为肝硬化发展铺路。
- 肝硬化阶段,持续组织损伤因实质丧失和纤维瘢痕增生导致纤维化严重程度增加。
- 组织学纤维化分期的效用反映在不同纤维化分期对应不同风险,而非侵入性纤维化评估无法可靠区分这些分期。
关键数值与推荐
- 多数慢性肝病的组织学纤维化分期系统基于纤维化的分布范围和程度制定。
- ALD纤维化在纤维化进展、消退的致病机制以及未来预后相关ALD分期方法需考虑的临床背景中接受审视。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Histological fibrosis stage is one of the most important prognostic factors in compensated and decompensated alcohol-related liver disease (ALD). Morphological assessment of fibrosis is useful for patient stratification, enabling individualised management, and for evaluation of treatment effects in clinical studies. In contrast to most chronic liver diseases where fibrosis is portal-based, fatty liver disease (FLD) of alcoholic or non-alcoholic aetiology (NAFLD) is associated with a centrilobular pattern of injury which leads to perivenular fibrosis and/or pericellular fibrosis. Progression of FLD drives expansive pericellular fibrosis, linking vascular structures and paving the way for the development of cirrhosis. At the cirrhotic stage, ongoing tissue damage leads to increasing fibrosis severity due to parenchymal loss and proliferation of fibrous scars. Histologic fibrosis staging systems have been devised, based on topography and the extent of fibrosis, for most chronic liver diseases. The utility of histological staging is reflected in different risks associated with individual fibrosis stages which cannot be reliably distinguished by non-invasive fibrosis assessment. In contrast to NAFLD, ALD-specific staging systems that enable the standardised prognostication required for clinical management and trials are lacking. Although morphological similarities between NAFLD and ALD exist, differences in clinical and histological features may substantially limit the utility of established NAFLD-specific staging systems for prognostication in ALD. This review summarises morphological features of fibrosis in ALD and compares them to other chronic liver diseases, particularly NAFLD. ALD-related fibrosis is examined in the context of pathogenetic mechanisms of fibrosis progression, regression and clinical settings that need to be considered in future prognostically relevant ALD staging approaches.
引用
- Lackner C, Tiniakos D. Fibrosis and alcohol-related liver disease. J Hepatol. 2019. PMID: 30658730. doi:10.1016/j.jhep.2018.12.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。